Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
ZARS Pharma Inc. clinical trials
The registry lists 24 studies whose lead sponsor is ZARS Pharma Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 17, 2012.
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to ZARS Pharma Inc..
- ZARS Pharma Inc.24 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 24 of 24.
- Pharmacokinetic Study of Synera in Healthy VolunteersCompletedNCT01602757Phase 1
- Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in AdultsCompletedNCT00107835Phase 3
- S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Vascular Access Procedures in ChildrenCompletedNCT00125255Phase 3
- S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in AdultsCompletedNCT00110773Phase 3
- S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Skin Filler Injection in the FaceCompletedNCT00110760Phase 3
- Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer PainTerminatedNCT00126789Phase 3
- Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant PainTerminatedNCT00126763Phase 3
- Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the KneeCompletedNCT00108810Phase 2
- Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant PainTerminatedNCT00278824Phase 2
- Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) PainCompletedNCT00108771Phase 2
- Duration of Skin Numbing Effect Created by the S-Caine™ PeelCompletedNCT00110253Phase 3
- S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Non-Ablative Facial Laser Resurfacing in AdultsCompletedNCT00110747Phase 3
- Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the KneeCompletedNCT00488267Phase 3
- Lidocaine and Tetracaine Cream to Treat Postherpetic Neuralgia (PHN)CompletedNCT00609323Phase 2
- Pharmacokinetic Study of Synera™ in Neonates and InfantsSuspendedNCT00747669Phase 4
- Study Evaluating Heated Lidocaine/Tetracaine Topical Patch in Treatment of Patients With Shoulder Impingement SyndromeCompletedNCT01055444Phase 2
- Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger PointsCompletedNCT01106989Phase 2
- Study Evaluating a Heated Lidocaine and Tetracaine Topical Patch in the Treatment of Patients With Patellar TendinopathyCompletedNCT01111773Phase 2
- Safety and Efficacy Study of Triamcinolone Acetonide DuraPeel to Treat Hand DermatitisCompletedNCT00890968Phase 2
- Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel SyndromeCompletedNCT00991068Phase 2
- A Phase 3 Study to Evaluate the Long-Term Safety of ThermoProfen™ in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee.TerminatedNCT00532038Phase 3
- Evaluate the Depth and Duration of AnesthesiaCompletedNCT00891163Phase 4
- Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in ChildrenCompletedNCT00107822Phase 3
- S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Laser-Assisted Tattoo Removal in AdultsCompletedNCT00110734Phase 3